Less Common Viral Infections

Infectious Diseases of the Fetus and Newborn Infant

Volumn , Issue , 2011, Pages 905-916

  Maldonado, Yvonne A ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882489766     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6400-8.00030-4     Document Type: Chapter

References (191)

1. Ono S., Saito H., Igarash M. The etiology of papilloma of the larynx. Ann. Otol. 1957, 66:1119.
2. Almeida J.D., Oriel J.D. Wart virus. Br. J. Dermatol. 1970, 83:698.
3. Gissman L., et al. Human papillomavirus types 6 and 11: DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc. Natl. Acad. Sci. U. S. A. 1983, 80:560.
4. Walboomers J.M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189:12-19.
5. Schiffman M., Castle P.E. Human papillomavirus: epidemiology and public health. Arch. Pathol. Lab. Med. 2003, 127:930-934.
6. Wiley D.J., et al. External genital warts: diagnosis, treatment, and prevention. Clin. Infect. Dis. 2002, 35(Suppl 2):S210-S224.
7. Munoz N., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003, 348:518-527.
8. Clifford G.M., et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br. J. Cancer 2003, 89:101-105.
9. Schaffer A., Brotherton J., Booy R. Do human papillomavirus vaccines have any role in newborns and the prevention of recurrent respiratory papillomatosis in children?. J. Paediatr. Child. Health 2007, 43:579-580.
10. Allen A.L., Seigfried E.C. The natural history of condyloma in children. J. Am. Acad. Dermatol. 1998, 39:951.
11. Hajek E.F. Contribution to the etiology of laryngeal papilloma in children. J. Laryngol. 1956, 70:166.
12. Cook T.A., et al. Laryngeal papilloma: etiologic and therapeutic considerations. Ann. Otol. 1973, 82:649.
13. Quick C.A., et al. Relationship between condylomata and laryngeal papillomata. Ann. Otol. 1980, 89:467.
14. Watts D.H., et al. Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am. J. Obstet. Gynecol. 1998, 178:365.
15. Puranen M., et al. Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. Am. J. Obstet. Gynecol. 1996, 174:694.
16. Fredericks B.D., et al. Transmission of human papillomaviruses from mother to child. Aust. N. Z. J. Obstet. Gynaecol. 1993, 33:30.
17. Smith E.M., et al. The association between pregnancy and human papilloma virus prevalence. Cancer Detect. Prev. 1991, 15:397.
18. Pakarian F., et al. Cancer associated human papillomaviruses: perinatal transmission and persistence. Br. J. Obstet. Gynaecol. 1994, 101:514.
19. Cason J., et al. Perinatal infection and persistence of human papillomavirus types 16 and 18 in infants. J. Med. Virol. 1995, 47:209.
20. Sedlacek T.V., et al. Mechanism for human papillomavirus transmission at birth. Am. J. Obstet. Gynecol. 1989, 161:55.
21. Smith E.M., et al. Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission. Sex. Transm. Dis. 2004, 31:57.
22. Drut R., et al. Human papillomavirus, neonatal giant cell hepatitis and biliary duct atresia. Acta Gastroenterol. Latinoam. 1998, 28:27.
23. Dias E.P., et al. Congenital papillomas and papillomatoses associated with the human papillomavirus (HPV)-report on 5 cases. Rev. Paul. Med. 1995, 113:957.
24. Steinberg B.M., et al. Laryngeal papillomavirus infection during clinical remission. N. Engl. J. Med. 1983, 308:1261.
25. Hording U., et al. Prevalence of human papillomavirus types 11, 16 and 18 in cervical swabs: a study of 1362 pregnant women. Eur. J. Obstet. Gynecol. Reprod. Biol. 1990, 35:191.
26. Peng T., et al. Prevalence of human papillomavirus infections in term pregnancy. Am. J. Perinatol. 1990, 7:189.
27. Kemp E.A., et al. Human papillomavirus prevalence in pregnancy. Obstet. Gynecol. 1992, 79:649.
28. Fife K.H., Rogers R.E., Zwickl B.W. Symptomatic and asymptomatic cervical infections with human papillomavirus during pregnancy. J. Infect. Dis. 1987, 156:904.
29. Tang C.K., Shermeta D.W., Wood C. Congenital condylomata acuminata. Am. J. Obstet. Gynecol. 1978, 131:912.
30. Roman A., Fife K. Human papillomavirus DNA associated with foreskins of normal newborns. J. Infect. Dis. 1986, 153:855.
31. Avidano M.A., Singleton G.T. Adjuvant drug strategies in the treatment of recurrent respiratory papillomatosis. Otolaryngol. Head Neck Surg. 1995, 112:197.
32. Markowitz L.E., et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recomm. Rep. 2007, 56(RR-2):1-24.
33. Derkay C.S. Recurrent respiratory papillomatosis. Laryngoscope 2001, 111:57.
34. Chhetri D.K., Shapiro N.L. A scheduled protocol for the treatment of juvenile recurrent respiratory papillomatosis with intralesional cidofovir. Arch. Otolaryngol. Head Neck Surg. 2003, 129:1081.
35. Harper D.M., et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006, 367:1247-1255.
36. Roden R., Wu T.C. Preventative and therapeutic vaccines for cervical cancer. Expert. Rev. Vaccines 2003, 2:495.
37. Henle W., Henle G., Horwitz C.A. Epstein-Barr virus-specific diagnostic tests in infectious mononucleosis. Hum. Pathol. 1974, 5:551.
38. Fleisher G., et al. Primary Epstein-Barr virus infection in American infants: clinical and serological observations. J. Infect. Dis. 1979, 139:553.
39. Icart J., Didier J. Infections due to Epstein-Barr virus during pregnancy. J. Infect. Dis. 1981, 143:499.
40. Fleisher G., Bolognese R. Persistent Epstein-Barr virus infection and pregnancy. J. Infect. Dis. 1983, 147:982.
41. Le C.T., Chang S., Lipson M.H. Epstein-Barr virus infections during pregnancy. Am. J. Dis. Child. 1983, 137:466.
42. Icart J., et al. Etude prospective de l'infection à virus Epstein-Barr (EBV) au cours de la grossesse. Biomedicine 1981, 34:160.
43. Gervais F., Joncas J.H. Seroepidemiology in various population groups of the greater Montreal area. Comp. Immunol. Microbiol. Infect. Dis. 1979, 2:207.
44. Horowitz C.A., et al. Long-term serologic follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis. J. Infect. Dis. 1985, 151:1150.
45. Fleisher G., Bolognese R. Epstein-Barr virus infections in pregnancy: a prospective study. J. Pediatr. 1984, 104:374.
46. Fleisher G., Bolognese R. Infectious mononucleosis during gestation: report of three women and their infants studied prospectively. Pediatr. Infect. Dis. 1984, 3:308.
47. Tallqvist H., et al. Antibodies to Epstein-Barr virus at the ages of 6 to 23 months in children with congenital heart disease. Scand. J. Infect. Dis. 1973, 5:159.
48. Brown Z.A., Stenchever M.A. Infectious mononucleosis and congenital anomalies. Am. J. Obstet. Gynecol. 1978, 131:108.
49. Goldberg G.N., et al. In utero Epstein-Barr virus (infectious mononucleosis) infection. JAMA 1981, 246:1579.
50. Weaver L.T., Nelson R., Bell T.M. The association of extrahepatic bile duct atresia and neonatal Epstein-Barr virus infection. Acta Paediatr. Scand. 1984, 73:155.
51. Visintine A.J., Gerber P., Nahmias A.J. Leukocyte transforming agent (Epstein-Barr virus) in newborn infants and older individuals. J. Pediatr. 1976, 89:571.
52. Chang R.S., Blankenship W. Spontaneous in vitro transformation of leukocytes from a neonate. Proc. Soc. Exp. Biol. Med. 1973, 144:337.
53. Chang R.S., Seto D.Y. Perinatal infection by Epstein-Barr virus. Lancet 1979, 2:201.
54. Joncas J., et al. Epstein-Barr virus in the neonatal period and in childhood. Can. Med. Assoc. J. 1974, 110:33.
55. Joncas J.H., Wills A., McLaughlin B. Congenital infection with cytomegalovirus and Epstein-Barr virus. Can. Med. Assoc. J. 1977, 117:1417.
56. Meyohas M.C., et al. Study of mother-to-child Epstein-Barr virus transmission by means of nested PCRs. J. Virol. 1996, 70:6816.
57. Joncas J., et al. Dual congenital infection with the Epstein-Barr virus (EBV) and the cytomegalovirus (CMV). N. Engl. J. Med. 1981, 304:1399.
58. Sixbey J.W., Lemon S.M., Pagano J.S. A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet 1986, 2:1122.
59. Portnoy J., et al. Recovery of Epstein-Barr virus from genital ulcers. N. Engl. J. Med. 1984, 311:966.
60. Horwitz C.A., et al. Fatal illness in a 2 week old infant: diagnosis by detection of Epstein-Barr virus genomes from a lymph node biopsy. J. Pediatr. 1983, 103:752.
61. Gervais F., Joncas J.H. Correspondence-an unusual antibody response to Epstein-Barr virus during infancy. J. Infect. Dis. 1979, 140:273.
62. Salahuddin S.Z., et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986, 234:596.
63. Lopez C., et al. Characteristics of human herpesvirus-6. J. Infect. Dis. 1988, 157:1271.
64. Leach C.T., Sumaya C.V., Brown N.A. Human herpesvirus-6: clinical implications of a recently discovered, ubiquitous agent. J. Pediatr. 1992, 1231:173.
65. Lawrence G.L., et al. Human herpes virus 6 is closely related to human cytomegalovirus. J. Virol. 1989, 64:287.
66. Baillargeon J., Piper J., Leach C.T. Epidemiology of human herpesvirus 6 (HHV-6) infection in pregnant and non-pregnant women. J. Clin. Virol. 2000, 16:149.
67. Dahl H., et al. Reactivation of human herpesvirus 6 during pregnancy. J. Infect. Dis. 1999, 180:2035.
68. Adams O., et al. Congenital infections with human herpesvirus 6. J. Infect. Dis. 1998, 178:544.
69. Yamaniski K., et al. Exanthem subitum and human herpes virus 6. Pediatr. Infect. Dis. J. 1993, 12:204.
70. Caserta M.T., et al. Human herpesvirus (HHV)-6 and HHV-7 infections in pregnant women. J. Infect. Dis. 2007, 196:1296-1303.
71. Aubi J.T., et al. Intrauterine transmission of human herpes virus 6. Lancet 1992, 340:482.
72. Dunne W.M., Demmler G.J. Serologic evidence for congenital transmission of human herpesvirus 6. Lancet 1992, 340:121.
73. van Loon N.M., et al. Direct sequence analysis of human herpesvirus 6 (HHV-6) sequences from infants and comparison of HHV-6 from mother/infant pairs. Clin. Infect. Dis. 1995, 21:1017.
74. Pruksananonda P., et al. Primary human herpes virus 6 infection in young children. N. Engl. J. Med. 1992, 22:1445.
75. Kawaguchi S., et al. Primary human herpesvirus 6 infection (exanthem subitum) in the newborn. Pediatrics 1992, 90:628.
76. Tajiri H., et al. Human herpesvirus-6 infection with liver injury in neonatal hepatitis. Lancet 1990, 335:863.
77. Asano Y., et al. Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection. Lancet 1990, 335:862.
78. Kanegane C., et al. Mononucleosis-like illness in an infant associated with human herpesvirus 6 infection. Acta Paediatr. Jpn. 1995, 37:227.
79. Hammerling J.A., et al. Prevalence of human herpesvirus 6 in lung tissue from children with pneumonitis. J. Clin. Pathol. 1996, 49:802.
80. Knox K.K., et al. Progressive immunodeficiency and fatal pneumonitis associated with human herpesvirus 6 infection in an infant. Clin. Infect. Dis. 1995, 20:406.
81. Black J.B., Pellett P.E. Human herpesvirus 7. Rev. Med. Virol. 1993, 3:217.
82. Frenkel N., et al. Isolation of a new herpesvirus from human CD4+ T cells. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:748.
83. Krueger G.R., et al. Comparison of seroprevalences of human herpesvirus-6 and -7 in healthy blood donors from nine countries. Vox. Sang. 1998, 75:193.
84. Clark D.A., et al. Prevalence of antibody to human herpesvirus 7 by age. J. Infect. Dis. 1993, 168:251.
85. Fujisaki H., et al. Detection of human herpesvirus 7 (HHV-7) DNA in breast milk by polymerase chain reaction and prevalence of HHV-7 antibody in breast-fed and bottle-fed children. J. Med. Virol. 1998, 56:275.
86. Lanphear B.P., et al. Risk factors for the early acquisition of human herpesvirus 6 and human herpesvirus 7 infections in children. Pediatr. Infect. Dis. J. 1998, 17:792.
87. Okuno T., et al. Human herpesviruses 6 and 7 in cervixes of pregnant women. J. Clin. Microbiol. 1995, 133:1968.
88. Boutolleau D., et al. No evidence for a major risk of roseolovirus vertical transmission during pregnancy. Clin. Infect. Dis. 2003, 36:1634.
89. Torigoe S., et al. Clinical manifestations associated with human herpesvirus 7 infection. Arch. Dis. Child. 1995, 72:518.
90. Torigoe S., et al. Human herpesvirus 7 infection associated with central nervous system manifestations. J. Pediatr. 1996, 129:301.
91. Clark D.A., et al. Diagnosis of primary human herpesvirus 6 and 7 infections in febrile infants by polymerase chain reaction. Arch. Dis. Child. 1997, 77:42.
92. Portolani M., et al. Isolation of human herpesvirus 7 from an infant with febrile syndrome. J. Med. Virol. 1995, 45:282.
93. Coffey V.P., Jessup W.J.E. Maternal influenza and congenital deformities. Lancet 1959, 2:935.
94. Doll R., Hill A.B. Asian influenza in pregnancy and congenital defects. Br. J. Prev. Soc. Med. 1960, 14:167.
95. Record R.G. Anencephalus in Scotland. Br. J. Prev. Soc. Med. 1961, 15:93.
96. Leck I. Incidence of malformations following influenza epidemics. Br. J. Prev. Soc. Med. 1963, 17:70.
97. Hakosalo J., Saxen L. Influenza epidemic and congenital defects. Lancet 1971, 2:1346.
98. Wilson M.G., Stein A.M. Teratogenic effects of Asian influenza. JAMA 1969, 210:336.
99. Hardy J.M.B., et al. The effect of Asian influenza on the outcome of pregnancy. Baltimore 1957-1958. Am. J. Public. Health 1961, 51:1182.
100. MacKenzie J.S., Houghton M. Influenza infections during pregnancy: association with congenital malformations and with subsequent neoplasms in children, and potential hazards of live virus vaccines. Bacteriol. Rev. 1974, 38:356.
101. Griffiths P.D., Ronalds C.J., Heath R.B. A prospective study of influenza infections during pregnancy. J. Epidemiol. Commun. Health 1980, 34:124.
102. Monif G.R.G., Soward D.L., Eitzman D.V. Serologic and immunologic evaluation of neonates following maternal influenza infection during the second and third trimesters. Am. J. Obstet. Gynecol. 1972, 114:239.
103. Hartert T.V., et al. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am. J. Obstet. Gynecol. 2003, 189:1705.
104. Englund J.A. Maternal immunization with inactivated influenza vaccine: rationale and experience. Vaccine 2003, 21:3460.
105. Mortensen P.B., et al. Individual and familial risk factors for bipolar affective disorders in Denmark. Arch. Gen. Psychiatry 2003, 60:1209.
106. Limosin F., et al. Prenatal exposure to influenza as a risk factor for adult schizophrenia. Acta Psychiatr. Scand. 2003, 107:331.
107. Brown A.S., Susser E.S. In utero infection and adult schizophrenia. Ment. Retard. Dev. Disabil. Res. Rev. 2002, 8:51.
108. Ruben F.L., Winkelstein A., Sabbagha R.E. In utero sensitization with influenza virus in man. Proc. Soc. Exp. Biol. Med. 1975, 149:881.
109. McGregor J.A., et al. Transplacental passage of influenza A/Bangkok (H3N2) mimicking amniotic fluid infection syndrome. Am. J. Obstet. Gynecol. 1984, 149:856.
110. Yawn D.H., et al. Transplacental transfer of influenza virus. JAMA 1971, 216:1022.
111. Ramphal R., Donnelly W.H., Small P.A. Fatal influenzal pneumonia in pregnancy: failure to demonstrate transplacental transmissions of influenza virus. Am. J. Obstet. Gynecol. 1980, 138:347.
112. Puck J.M., et al. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J. Infect. Dis. 1980, 142:844.
113. Reuman P.D., Ayoub E.M., Small P.A. Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs. Pediatr. Infect. Dis. J. 1987, 6:398.
114. Bauer C.R., et al. Hong Kong influenza in a neonatal unit. JAMA 1973, 223:1233.
115. Joshi V.V., et al. Fatal influenza A2 viral pneumonia in a newborn infant. Am. J. Dis. Child. 1973, 126:839.
116. Meibalane R., et al. Outbreak of influenza in a neonatal intensive care unit. J. Pediatr. 1977, 91:974.
117. Sumaya C.V., Gibbs R.S. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mothers and infants. J. Infect. Dis. 1979, 140:141.
118. Schmidt J.V., Kroger A.T., Roy S.L. Report from the CDC. Vaccines in women. J. Womens Health (Larchmt) 2004, 13:249.
119. Holberg C.J., et al. Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am. J. Epidemiol. 1991, 133:1135.
120. Chanock R.M., et al. Influence of immunological factors in respiratory syncytial virus disease. Arch. Environ. Health 1970, 21:347.
121. Jacobs J.W., et al. Respiratory syncytial and other viruses associated with respiratory disease in infants. Lancet 1971, 1:871.
122. Parrott R.H., Kim H.W., Arrobio J.O. Epidemiology of respiratory syncytial virus infection in Washington, DC. II. Infection and disease with respect to age, immunologic status, race and sex. Am. J. Epidemiol. 1973, 98:289.
123. Bruhn F.W., Yeager A.S. Respiratory syncytial virus in early infancy. Am. J. Dis. Child. 1977, 131:145.
124. Lamprecht C.L., Krause H.E., Mufson M.A. Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus. J. Infect. Dis. 1976, 134:211.
125. Glezen W.P., et al. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J. Pediatr. 1981, 98:708.
126. Downham M., et al. Breast-feeding protects against respiratory syncytial virus infections. BMJ 1976, 2:274.
127. Bruhn F.W., Mokrohisky S.T., McIntosh K. Apnea associated with respiratory syncytial virus infection in young infants. J. Pediatr. 1977, 90:382.
128. Abzug M.J., et al. Viral pneumonia in the first month of life. Pediatr. Infect. Dis. J. 1990, 9:881.
129. MacDonald N.E., et al. Respiratory syncytial viral infection in infants with congenital heart disease. N. Engl. J. Med. 1982, 307:397.
130. Abman S.H., et al. Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J. Pediatr. 1988, 113:826.
131. McConnochie K.M., et al. Variation in severity of respiratory syncytial virus infections with subtype. J. Pediatr. 1990, 117:52.
132. Neligan G.A., et al. Respiratory syncytial virus infection of the newborn. BMJ 1970, 3:146.
133. Berkovich S., Taranko L. Acute respiratory illness in the premature nursery associated with respiratory syncytial virus infection. Pediatrics 1964, 34:753.
134. Mintz L., et al. Nosocomial respiratory syncytial virus infections in an intensive care nursery: rapid diagnosis by direct immunofluorescence. Pediatrics 1979, 64:149.
135. Goldson E.J., et al. A respiratory syncytial virus outbreak in a transitional care nursery. Am. J. Dis. Child. 1979, 133:1280.
136. Church N.R., Anas N.G., Hall C.B. Respiratory syncytial virus-related apnea in infants: demographics and outcome. Am. J. Dis. Child. 1984, 138:247.
137. Valenti W.M., et al. Concurrent outbreaks of rhinovirus and respiratory syncytial virus in an intensive care nursery: epidemiology and associated risk factors. J. Pediatr. 1982, 100:722.
138. Meissner H.C., et al. A simultaneous outbreak of respiratory syncytial virus and parainfluenza virus type 3 in a newborn nursery. J. Pediatr. 1984, 104:680.
139. Wensley D.F., Baldwin V.J. Respiratory distress in the second week of life. J. Pediatr. 1985, 106:326.
140. Hall C.B., et al. Neonatal respiratory syncytial virus infection. N. Engl. J. Med. 1979, 300:393.
141. Wilson C.W., Stevenson D.K., Arvin A.M. A concurrent epidemic of respiratory syncytial virus and echovirus 7 infections in an intensive care nursery. Pediatr. Infect. Dis. J. 1989, 8:24.
142. Unger A., et al. Atypical neonatal respiratory syncytial virus infection. J. Pediatr. 1982, 100:762.
143. Hall C.B., Douglas R.G., Geiman J.M. Respiratory syncytial virus infections in infants: quantitation and duration of shedding. J. Pediatr. 1976, 89:11.
144. Hall C.B., Douglas R.G., Geiman J.M. Possible transmission by fomites or respiratory syncytial virus. J. Infect. Dis. 1980, 141:98.
145. Snydman D.R., et al. Prevention of nosocomial transmission of respiratory syncytial virus in a newborn nursery. Infect. Control. Hosp. Epidemiol. 1988, 9:105.
146. Leclair J.M., et al. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N. Engl. J. Med. 1987, 317:329.
147. Agah R., et al. Respiratory syncytial virus (RSV) infection rate in personnel caring for children with RSV infections: routine isolation procedure vs routine procedure supplemented by use of masks and goggles. Am. J. Dis. Child. 1987, 141:695.
148. Hall C.B., et al. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection: a randomized double-blind study. N. Engl. J. Med. 1983, 308:1443.
149. Hall C.B., et al. Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA 1985, 254:3047.
150. Rodriguez W.J., et al. Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease. Pediatr. Infect. Dis. J. 1987, 6:159.
151. Conrad D.A., et al. Aerosolized ribavirin treatment of respiratory syncytial virus infection in infants hospitalized during an epidemic. Pediatr. Infect. Dis. J. 1987, 6:152.
152. Outwater K.M., Meissner H.C., Peterson M.B. Ribavirin administration to infants receiving mechanical ventilation. Am. J. Dis. Child. 1988, 142:512.
153. Frankel L.R., et al. A technique for the administration of ribavirin to mechanically ventilated infants with severe respiratory syncytial virus infection. Crit. Care Med. 1987, 15:1051.
154. Wald E.R., Dashefsky B., Green M. In re ribavirin. A case of premature adjudication. J. Pediatr. 1988, 112:154.
155. Prober C.G., Wang E.E.L. Reducing the morbidity of lower respiratory tract infections caused by respiratory syncytial virus: still no answer. Pediatrics 1997, 99:472.
156. American Academy of Pediatrics Committee on Infectious Diseases. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics 1996, 97:137.
157. Ribavirin therapy of respiratory syncytial virus. Report of the Committee on Infectious Diseases 1991, American Academy of Pediatrics, Elk Grove Village, IL. P.G. Lepow, M.L. McCrachen, C.F. Phillips (Eds.).
158. Meissner H.C., Long S.S. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 2003, 112:1447.
159. Red Book: Report of the Committee on Infectious Diseases 2006, American Academy of Pediatrics, Elk Grove Village, IL. twenty seventh ed. L.K. Pickering (Ed.).
160. Moler F.W., et al. Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience. Crit. Care Med. 1992, 20:1406.
161. Navas L., et al. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. J. Pediatr. 1992, 121:348.
162. Anderson L.J., et al. Day-care center attendance and hospitalization for lower respiratory tract illness. Pediatrics 1988, 82:300.
163. Diebel R., et al. Lymphocytic choriomeningitis virus in man: serologic evidence of association with pet hamster. JAMA 1975, 232:501.
164. Smadel J.E., Wall M.J. Lymphocytic choriomeningitis in the Syrian hamster. J. Exp. Med. 1942, 75:581.
165. Traub E. Persistence of lymphochoriomeningitis virus in immune animals and its relation to immunity. J. Exp. Med. 1936, 63:847.
166. Komrower G.M., Williams B.L., Stones P.B. Lymphocytic choriomeningitis in the newborn. Lancet 1955, 1:697.
167. Biggar R.J., et al. Lymphocytic choriomeningitis outbreak associated with pet hamsters: fifty-seven cases from New York state. JAMA 1975, 232:494.
168. Hotchin J. The contamination of laboratory animals with lymphocytic choriomeningitis virus. Am. J. Pathol. 1971, 64:747.
169. Sheinbergas M.M. Hydrocephalus due to prenatal infection with the lymphocytic choriomeningitis virus. Infection 1974, 4:185.
170. Ackermann R., Stammler A., Armbruster B. Isolierung von Virus der lymphozytären Choriomeningitis aus Abrasionsmaterial nach Kontakt der Schwangeren mit einem Syrischen Goldhamster (Mesocricetus auratus). Infection 1975, 3:47.
171. Wright R., et al. Congenital lymphocytic choriomeningitis virus syndrome: a disease that mimics congenital toxoplasmosis or cytomegalovirus infection. Pediatrics 1997, 100:E9.
172. Ackermann R., et al. Pränatale Infektion mit dem Virus der lymphozytären Choriomeningitis. Dtsch. Med. Wochenschr. 1974, 99:629.
173. Mets M.B., et al. Lymphocytic choriomeningitis virus: an underdiagnosed cause of congenital chorioretinitis. Am. J. Ophthalmol. 2000, 130:209.
174. Chastel C., et al. Infection transplacentaire par le virus de la choriomeningite lymphocytaire. Nouv. Presse Med. 1978, 71:1089.
175. Wilkin J.K. Molluscum contagiosum venereum in a women's outpatient clinic: a venereally transmitted disease. Am. J. Obstet. Gynecol. 1977, 128:531.
176. Mandel M.J., Lewis R.J. Molluscum contagiosum of the newborn. Br. J. Dermatol. 1970, 84:370.
177. Young W.J. Molluscum contagiosum with unusual distribution. Ky. Med. J. 1926, 24:467.
178. Cates W. Treatment of rabies exposure during pregnancy. Obstet. Gynecol. 1974, 44:893.
179. Martell M.A., Montes F.C., Alcocer R.B. Transplacental transmission of bovine rabies after natural infection. J. Infect. Dis. 1973, 127:291.
180. Geneverlay J., Dodero J. Note sur un enfant né d'une mere en etat du rage. Ann. Inst. Pasteur Paris 1935, 55:124.
181. Viazhevich V.K. A case of birth of a healthy baby to a mother during the incubation period of rabies. Zh. Mikrobiol. Epidemiol. Immunobiol. 1957, 28:1022.
182. Machada C.G., et al. Observations sur un enfant né de mere atteinte de rage et soumis du traitement prophylactique par le serum et le vaccome amtorabiques. Bull. Soc. Pathol. Exp. 1966, 59:764.
183. Relova R.N. The hydrophobia boy. J. Philipp. Med. Assoc. 1963, 39:765.
184. Spence M.R., et al. Rabies exposure during pregnancy. Am. J. Obstet. Gynecol. 1975, 123:655.
185. Meyer H.M. FDA: rabies vaccine. J. Infect. Dis. 1980, 142:287.
186. Public Health Service Advisory Committee on Immunization Practices Human Rabies Prevention-United States, 1999 Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly. Rep. 1999, 48:1.
187. Nash D., et al. The outbreak of West Nile infection in the New York City area in 1999. N. Engl. J. Med. 2001, 344:1807.
188. Centers for Disease Control and Prevention Intrauterine West Nile virus infection-New York, 2002. MMWR Morb. Mortal. Wkly. Rep. 2002, 51:1135.
189. Alpert S.G., Fergerson J., Noel L.P. Intrauterine West Nile virus: ocular and systemic findings. Am. J. Ophthalmol. 2003, 136:733.
190. Centers for Disease Control and Prevention Possible West Nile virus transmission to an infant through breast-feeding-Michigan, 2002. MMWR Morb. Mortal. Wkly. Rep. 2002, 51:877.
191. Centers for Disease Control and Prevention Interim guidelines for the evaluation of infants born to mothers infected with West Nile virus during pregnancy. MMWR Morb. Mortal. Wkly. Rep. 2004, 53:154.